Yanimo Respimat 2.5 µg/dose - 2.5 µg/dose inhal. sol. cartr.

Pays: Belgique

Langue: anglais

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingrédients actifs:

Tiotropium Bromide Monohydrate 3,1 µg/dose - Eq. Tiotropium 2,5 µg/dose; Olodaterol Hydrochloride 2,7 µg/dose - Eq. Olodaterol 2,5 µg/dose

Disponible depuis:

Boehringer Ingelheim International GmbH

Code ATC:

R03AL06

DCI (Dénomination commune internationale):

Tiotropium Bromide Monohydrate; Olodaterol Hydrochloride

Dosage:

2,5 µg/dose - 2,5 µg/dose

forme pharmaceutique:

Inhalation solution

Composition:

Tiotropium Bromide Monohydrate 3.1 µg/dose; Olodaterol Hydrochloride 2.7 µg/dose

Mode d'administration:

Inhalation use

Domaine thérapeutique:

Olodaterol and Tiotropiumbromide

Descriptif du produit:

CTI code: 475102-02 - Pack size: 2 x 60 doses (4 (4) + 2 x Inhaler - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 475102-03 - Pack size: 3 x 60 doses (4 (4) + 3 x Inhaler - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 475102-01 - Pack size: 60 doses (4 (4) + 1 x Inhaler - Commercialisation status: YES - FMD code: 04048846017543 - CNK code: 3690997 - Delivery mode: Medical prescription; CTI code: 475102-06 - Pack size: 3 x 60 doses (4 (4) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 475102-07 - Pack size: 3 x 60 doses (4 (4) + 1 x Inhaler - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 475102-04 - Pack size: 8 x 60 doses (4 (4) + 8 x Inhaler - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 475102-05 - Pack size: 60 doses (4 (4) - Commercialisation status: NO - Delivery mode: Medical prescription

Statut de autorisation:

Commercialised: Yes

Date de l'autorisation:

2015-06-22